Total Google Ads revenue generated in just 4 months
Revenue generated from email flows in just 50 days
The peptides space is one of the most difficult product categories to advertise on Google. The products sit in a regulatory gray area – not outright banned, but constantly flagged. Headlines get disapproved. Product listings get pulled. Descriptions trigger policy violations. Running a clean, compliant account in this niche requires constant attention, fast reactions, and a team that understands where the lines are.
When this US-based peptides brand came to us, their Google Ads account was essentially inactive. In October 2025, the month before we took over, they spent roughly $3,800 with minimal return. There was no real campaign structure, no intent-based targeting, and no path to scale. They knew Google Ads could be a major revenue channel for them, but they needed a team that could navigate the compliance complexity while actually driving results.
The original goal was straightforward: get above breakeven. Their breakeven ROAS was approximately 1.3x. That was the bar we needed to clear before we could start thinking about growth.
What happened over the next four months exceeded that target significantly.
Before Budai Media
After Budai Media
1. Building a Campaign Structure from the Ground Up
When we took over in November, the first priority was architecture. There was no existing structure worth salvaging, so we started fresh with a multi-campaign setup designed around one core principle: target people who already know what they want.
Peptides buyers are not casual browsers. They are researching specific compounds, specific products, specific forms. Broad terms like “peptides” attract low-intent traffic and policy headaches. Product-specific terms attract buyers ready to purchase.
With that in mind, we launched five campaign types simultaneously:
This layered approach meant we were covering the full funnel within Google’s ecosystem from day one, while keeping spend efficient by focusing on terms with genuine commercial intent.
November was slow by design. We spent $7.6K and generated $4.5K in revenue – a 0.6x ROAS. That is expected when campaigns are in the learning phase and compliance reviews are ongoing. The foundation was being laid.
2. Navigating Compliance in a Restricted Category
Advertising peptides on Google is not a set-and-forget operation. It requires ongoing management that most agencies either cannot handle or are not willing to take on.
Throughout the campaign period, we dealt with repeated disapprovals across headlines, descriptions, and product listings. Each disapproval required us to rewrite copy, adjust the website, and in some cases remove links entirely to satisfy Google’s policy reviewers. Then appeal. Then monitor. Then repeat.
In February, the brand also had to change their site URLs – a significant disruption because URL changes force campaigns back into the learning phase, effectively resetting the optimization progress built over the previous months. On top of that, the site was gated behind account creation at the end of February, meaning new visitors had to register before they could even browse products.
Both of these changes put pressure on conversion rate. But the account held. By March, conversion rate was sitting at approximately 3.6%, which is strong for a gated site in a restricted category.
Managing this level of compliance complexity while continuing to scale spend is one of the core reasons results in this account look the way they do.
3. Scaling Spend as Performance Justified It
Once campaigns started gaining traction in mid-December, we scaled deliberately. The goal was never to spend more for the sake of it. Spend increased only when ROAS data supported it.
The month-by-month progression tells the story clearly:
December was the turning point. Campaigns found their footing mid-month, ROAS jumped to 2.8x, and that gave us the confidence to scale into January. January more than tripled December’s revenue. February more than doubled January’s.
Total spend across the four months was $194K. Total revenue generated was $426K. That is a 2.2x return on the full period, in a category where most advertisers struggle to stay compliant, let alone profitable.
At the campaign level, standout performance included click-through rates reaching up to 47%, conversion rates on individual campaigns hitting up to 20%, and conversion value/cost ratios peaking at 3.5x on the strongest campaigns. Average CPC across the account held at $3.76 – efficient for a niche where compliance restrictions limit the advertiser pool but also limit how aggressively you can bid.
From November 2025 to February 2026, this peptides brand went from a dormant Google Ads account to one generating $286K in a single month.
Key Metrics (November 2025 – February 2026):
The account has continued to perform into March, with daily revenue running at approximately $10K and ROAS holding around 2x despite the site gating and URL migration that took place in late February.
1. Speed of lift matters as much as the ceiling.
Going from $4.5K to $286K in monthly revenue across four months is not a slow build. It is aggressive, deliberate scaling backed by data at every step. The goal was never to hit breakeven and sit there – it was to clear breakeven fast and then scale with confidence.
2. Restricted categories reward specialists.
Peptides advertising on Google is difficult enough that many agencies will not touch it. The constant compliance management – disapproved ads, copy rewrites, site changes, URL migrations – is work that requires experience and patience. Brands in gray-area categories need a team that understands the rules well enough to operate right up to the edge of them.
3. Campaign structure determines scale potential.
Launching five campaign types from day one was not overcomplicated – it was deliberate. Each campaign type served a different role. Search captured active buyers. PMax prioritized high-margin products. Dynamic Search Ads caught long-tail demand. Without that foundation, scaling spend would have meant scaling waste.
4. Learning phases are an investment, not a failure.
November’s 0.6x ROAS looked bad on paper. But it was the price of building campaigns that could eventually run at 2.8x and above. Brands that pull the plug too early in the learning phase never see what their campaigns are capable of.
5. Resilience is a result too.
The URL changes and site gating in February could have collapsed performance. They did not. Conversion rate held above 3%, revenue hit a new high, and the account kept scaling. That resilience is a direct result of the campaign architecture built in the months before.
When this peptides brand came to us, their email marketing was nonexistent. No flows, no automations, no sequences of any kind. Every subscriber on their list was receiving nothing after they signed up. That meant every visitor who gave their email was essentially being left on the table.
We started by setting up their email infrastructure on Klaviyo. Then Klaviyo banned the account – peptides brands are not permitted on the platform. So we migrated everything to Fluent CRM and rebuilt from scratch without missing a beat.
We also set up popups to capture new subscribers. Once the brand gated their site behind account creation (a legal requirement in their category), every visitor was already submitting their email to enter. The popups became redundant and we switched them off. The site gate was doing the capture work for us.
From there, we built 8 flows covering the full customer lifecycle. Six of those flows have been live for approximately 50 days. The results across that window speak for themselves.
The Welcome Flow is the first impression every new subscriber gets. We structured it as a four-email sequence: a thank you for subscribing, a proper brand welcome, a showcase of the most popular peptides, and a final email featuring top-rated, lab-tested products. The goal was to move new subscribers from curiosity to purchase by building trust and highlighting proof before asking for anything.
Open rates averaged around 40% with click rates of 2-3% and notably low unsubscribe rates – strong signals that the content was relevant and the send cadence was right.
A seven-email sequence targeting visitors who browsed products but left without purchasing. The sequence opens with a direct re-engagement (“Ready to come back to your order?”), follows up with a softer nudge (“Still interested?”), and then shifts to highlighting free shipping as an incentive to return.
Open rates held around 40%, with strong click rates throughout the sequence – this is one of the highest-revenue flows in the account despite only going live on March 17th.
Eight emails targeting shoppers who reached checkout but did not complete their purchase. The sequence starts with straightforward reminders, then introduces a 10% discount to close the gap, and escalates to 15% for those who still have not converted. Open rates averaged just under 40% with click rates reaching up to 6%.
A six-email sequence for first-time buyers designed to drive a second purchase and build long-term loyalty. Open rates reached up to 73% and click rates hit up to 13% – both well above typical post-purchase benchmarks. Buyers who just converted are at peak engagement, and this flow capitalizes on that window.
A separate six-email sequence for repeat buyers, keeping them engaged and driving additional purchases. Open rates reached up to 77% with strong click rates. The separation between new and returning customer flows matters here – messaging that works for a first-time buyer is not the same as what resonates with someone already familiar with the brand.
A three-email sequence for the brand’s highest-value customers. Open rates were consistently above 60% and click rates reached up to 13%. This is a smaller segment by volume, which is reflected in the revenue figure – but the engagement rates here are among the strongest in the account.
Six flows live. Two more (Win-back and Replenishment) built and ready to generate revenue as the eligible audience grows. Combined revenue across all active flows: approximately $180K in roughly 50 days – from a starting point of zero.
No inherited list. No existing automations. No head start. Everything here was built from scratch on a platform we were forced to migrate to after a mid-setup ban. The revenue is entirely new, generated by infrastructure that did not exist before we came in.
For a brand in a restricted category where paid acquisition requires constant compliance management, email has become a reliable and growing revenue channel in a matter of weeks.
Four months of Google Ads. Fifty days of email. One brand that came to us with no paid infrastructure and no email flows in place.
When this peptides brand came to us, the bar was simply to break even on Google Ads. By February, they were generating $286K in a single month from paid search alone – in one of the most compliance-heavy advertising categories on the platform. At the same time, a full email system built from scratch on a migrated platform was generating $182K in revenue across six flows, in under two months.
The results across both channels came from the same principle: build the right foundation, don’t cut corners, and scale only when the data justifies it. On Google Ads that meant a structured multi-campaign setup and constant compliance management. On email it meant eight flows covering the full customer lifecycle, built from zero after a mid-setup platform ban.
Neither channel was accidental. And together, they tell the story of what’s possible when the full retention picture is taken seriously from day one.
Momentum has carried into March across both channels. The foundation is solid and the runway is long.
Are you ready to unlock new levels of growth with our expert Ecommerce Marketing services?
